Association between mortality and implantable cardioverter‐defibrillators by aetiology of heart failure: a propensity‐matched analysis of the WARCEF trial

AIMS: There is debate on whether the beneficial effect of implantable cardioverter‐defibrillators (ICDs) is attenuated in patients with non‐ischaemic cardiomyopathy (NICM). We assess whether any ICD benefit differs between patients with NICM and those with ischaemic cardiomyopathy (ICM), using data...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Tetz C., Qian, Min, Mu, Lan, Di Tullio, Marco R., Graham, Susan, Mann, Douglas L., Nakanishi, Koki, Teerlink, John R., Lip, Gregory Y.H., Freudenberger, Ronald S., Sacco, Ralph L., Mohr, Jay P., Labovitz, Arthur J., Ponikowski, Piotr, Lok, Dirk J., Estol, Conrado, Anker, Stefan D., Pullicino, Patrick M., Buchsbaum, Richard, Levin, Bruce, Thompson, John L.P., Homma, Shunichi, Ye, Siqin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437435/
https://www.ncbi.nlm.nih.gov/pubmed/30816013
http://dx.doi.org/10.1002/ehf2.12407

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437435/
https://www.ncbi.nlm.nih.gov/pubmed/30816013
http://dx.doi.org/10.1002/ehf2.12407

Ejemplares similares